Want to see DCGO full AI Analyst Report?
DCGO Stock Chart & Stats
$0.38
-$0.07(-11.07%)
At close: 4:00 PM EDT
$0.38
-$0.07(-11.07%)
Day’s Range― - ―
52-Week Range$0.24 - $1.65
Previous CloseN/A
Volume791.43K
Average Volume (3M)631.99K
Market Cap
$25.23M
Enterprise Value$28.39M
Total Cash (Recent Filing)$25.23M
Total Debt (Recent Filing)$25.91M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Nov 09, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.96
Shares Outstanding98,992,350
10 Day Avg. Volume589,323
30 Day Avg. Volume631,993
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.60
Price to Sales (P/S)0.27
P/FCF Ratio3.22
Enterprise Value/Market Cap1.13
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit0.32
Enterprise Value/Ebitda-0.18
Forecast
1Y Price Target
$2.17Price Target Upside470.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.35
Revenue Forecast (FY)$306.63M
Bulls Say, Bears Say
Bulls Say
Organic Growth And Record Service VolumesUnderlying demand remains resilient despite the migrant-program wind-down, with double-digit growth in core revenue and record activity across transportation, in-home care, phlebotomy, monitoring, and virtual care. This broader volume base supports more durable scale and cross-selling potential.
AI And Efficiency InitiativesAutomation is already deployed in meaningful operating workflows rather than remaining a purely aspirational program. Higher automation, lower processing costs, and planned expansion across additional initiatives could improve scalability and help offset labor pressure over the next several quarters.
Expanded Care Platform Through Hicuity AcquisitionCombining virtual critical-care monitoring with mobile and in-home services could broaden DocGo’s offering to health systems and payers. A more integrated care-anywhere platform may create cross-sell opportunities and strengthen strategic relevance across multiple healthcare delivery settings.
Bears Say
Deepening Losses And Weak Revenue TrendThe company is facing both shrinking reported revenue and sharply negative operating performance, indicating that cost growth is overwhelming gross profit. Persistent losses reduce internal funding capacity and make the expected return to profitability dependent on successful execution of restructuring and growth initiatives.
Cash Burn And Tighter LiquidityRecent cash burn weakens financial flexibility at the same time that liquidity has declined. If negative cash generation persists, DocGo may need external financing or further cost reductions, limiting investment capacity and increasing the consequences of execution delays or weaker operating results.
Higher Secured Debt And Potential DilutionThe new financing provides liquidity but increases fixed obligations, lender restrictions, and asset encumbrance through 2029. The accompanying warrant can dilute shareholders, while high interest costs and covenant limits may constrain capital allocation if the business remains loss-making.
DocGo News
DCGO FAQ
What was DocGo’s price range in the past 12 months?
DocGo lowest stock price was $0.24 and its highest was $1.65 in the past 12 months.
What is DocGo’s market cap?
DocGo’s market cap is $25.23M.
When is DocGo’s upcoming earnings report date?
DocGo’s upcoming earnings report date is Nov 09, 2026 which is in 19 days.
How were DocGo’s earnings last quarter?
DocGo released its earnings results on Aug 17, 2026. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.098 by -$0.062.
Is DocGo overvalued?
According to Wall Street analysts DocGo’s price is currently Undervalued.
Does DocGo pay dividends?
DocGo does not currently pay dividends.
What is DocGo’s EPS estimate?
DocGo’s EPS estimate is -0.11.
How many shares outstanding does DocGo have?
DocGo has 98,992,350 shares outstanding.
What happened to DocGo’s price movement after its last earnings report?
DocGo reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.098. Following the earnings report the stock price went down -33.099%.
Which hedge fund is a major shareholder of DocGo?
Currently, no hedge funds are holding shares in DCGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DocGo
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
DCGO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed strong operational momentum (record volumes across multiple business lines, solid organic growth after excluding one-time migrant revenues, a strategic acquisition with committed financing, and tangible AI-driven efficiency programs) alongside material near-term financial pressures (widened adjusted EBITDA loss guidance, ongoing negative adjusted EBITDA, declining cash balances, margin compression in mobile health, and the addition of assumed Hicuity debt). Management expects improvements (positive adjusted EBITDA run rate exiting 2026) but execution and timing risks remain.View all DCGO earnings summariesDCGO Stock 12 Month Forecast
Average Price Target
$2.17
▲(470.18% Upside)
Technical Analysis
Addus Homecare
―
Viemed Healthcare
―
Aveanna Healthcare Holdings
―
EUDA Health Holdings
―
Mobile-health Network Solutions Class A
―
Ownership Overview
6.86% Insiders
8.24% Mutual Funds
15.51% Other Institutional Investors
65.07% Public Companies and
Individual Investors